SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
hta_chen
Lv1
30 积分
2022-01-27 加入
最近求助
最近应助
互助留言
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
19天前
已完结
Assessing the performance of alternative methods for estimating long-term survival benefit of immuno-oncology therapies
21天前
已完结
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
22天前
已完结
Cost-effectiveness analysis of sugemalimab in combination with chemotherapy as first-line treatment in Chinese patients with metastatic NSCLC
22天前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
22天前
已完结
Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study
27天前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
1个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
1个月前
已完结
MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation—A Tutorial
1个月前
已完结
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
1个月前
已完结
没有进行任何应助
只有摘要,没有文章全文。
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论